The University of Massachusetts Amherst is required by law to ensure that all research activities involving recombinant and synthetic nucleic acid molecule technology are reviewed in accordance with the NIH Guidelines. This includes unfunded projects, projects that are funded by an agency other than NIH. Registration must be submitted to the University of Massachusetts Amherst’s Institutional Biosafety Committee (IBC) for review to ensure that all provisions of the NIH Guidelines will be followed. Please complete and submit the attached rDNA Registration Form to: Barbara Miller, Office of Research Affairs (413-545-0668; email@example.com) for review to determine the NIH review level.
Go to Biological Safety Manual